Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Malignant Mesothelioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00551252
What this trial is testing

A Phase II Study of the Association of Glivec® Plus Gemzar® in Patients With Unresectable, Refractory, Malignant Mesothelioma

Who this might be right for
Mesothelioma
Gruppo Italiano MEsotelioma 56
Testing effectiveness (Phase 2)Temporarily pausedNCT05703854
What this trial is testing

Study of CAR.70-engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Advanced Renal Cell Carcinoma, Mesothelioma and Osteosarcoma

Who this might be right for
Advanced Renal Cell CarcinomaAdvanced MesotheliomaAdvanced Osteosarcoma
M.D. Anderson Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT00154388
What this trial is testing

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases

Who this might be right for
Life Threatening Diseases
Novartis Pharmaceuticals 185
Testing effectiveness (Phase 2)Study completedNCT02414945
What this trial is testing

TILs & Low-Dose IL-2 Therapy Following Cyclophosphamide and Fludarabine in Pleural Mesothelioma Patients

Who this might be right for
Pleural Mesothelioma
University Health Network, Toronto 9
Testing effectiveness (Phase 2)Study completedNCT01644994
What this trial is testing

Intracavitary Cisplatin-Fibrin Localized Chemotherapy After P/D or EPP for Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
University of Zurich 47
Testing effectiveness (Phase 2)WithdrawnNCT02661100
What this trial is testing

A Trial of CDX-1401 in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced Solid Tumor Patients

Who this might be right for
Non Small Cell Lung CancerAdvanced Triple Negative Breast CancerSmall Cell Lung Cancer+3 more
Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT02153229
What this trial is testing

Phase II Trial of Radical Pleurectomy With or Without Intraoperative PDT for Malignant Pleural Mesothelioma

Who this might be right for
Epitheliod Malignant Pleural Mesothelioma
Abramson Cancer Center at Penn Medicine 52
Testing effectiveness (Phase 2)Study completedNCT02610140
What this trial is testing

Phase II Anetumab Ravtansine as 2nd Line Treatment for Malignant Pleural Mesothelioma (MPM)

Who this might be right for
Mesothelioma
Bayer 248
Testing effectiveness (Phase 2)UnknownNCT03475953
What this trial is testing

A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors

Who this might be right for
Colorectal Cancer Not MSI-H or MMR-deficientGISTOesophageal or Gastric Carcinoma+12 more
Institut Bergonié 747
Testing effectiveness (Phase 2)Study completedNCT01211275
What this trial is testing

Standard Chemotherapy With of Without Axitinib in Malignant Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
The Netherlands Cancer Institute 32
Testing effectiveness (Phase 2)Study completedNCT00087698
What this trial is testing

Phase II Trial of Neo-Adjuvant Pemetrexed Plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma

Who this might be right for
Pleural Neoplasms
Eli Lilly and Company 77
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06603987
What this trial is testing

Using CICS-1 and SPM-011 and ［18F］FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA

Who this might be right for
Thoracic Solid Malignant Tumor
Stella Pharma Corporation 30
Early research (Phase 1)Study completedNCT00006981
What this trial is testing

Immunotoxin Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Cervical CancerFallopian Tube CancerHead and Neck Cancer+5 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT02588131
What this trial is testing

Tremelimumab Combined With the Anti-PD-L1 MEDI4736 Antibody in Malignant Mesothelioma (NIBIT-MESO-1)

Who this might be right for
Pleural MesotheliomaPeritoneal Mesothelioma
Italian Network for Tumor Biotherapy Foundation 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT00715611
What this trial is testing

Pleurectomy/Decortication (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural Mesothelioma

Who this might be right for
Mesothelioma
Memorial Sloan Kettering Cancer Center 65
Testing effectiveness (Phase 2)UnknownNCT01569919
What this trial is testing

A Phase II Trial to Assess TroVax® Plus Chemotherapy in Patients With Malignant Pleural Mesothelioma

Who this might be right for
MalignantPleuralMesothelioma
Wales Cancer Trials Unit 26
Testing effectiveness (Phase 2)WithdrawnNCT01353482
What this trial is testing

A Phase I/II Study of First Line Vorinostat With Pemetrexed-cisplatin, in Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
University College, London
Testing effectiveness (Phase 2)Study completedNCT00787410
What this trial is testing

An Open-label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant Mesothelioma

Who this might be right for
Mesothelioma
AstraZeneca 23
Testing effectiveness (Phase 2)Study completedNCT05136677
What this trial is testing

Evaluate Nivolumab in Combination With Ipilimumab Versus Pemetrexed With Cisplatin or Carboplatin for Unresectable Pleural Mesothelioma in Chinese Participants

Who this might be right for
Mesothelioma, Malignant
Bristol-Myers Squibb 102
Testing effectiveness (Phase 2)Ended earlyNCT00859495
What this trial is testing

Trimodal Lung-Sparing Treatment of Pleural Mesothelioma

Who this might be right for
Pleural Mesothelioma
Columbia University 9
Next Page